Manufacturing, artificial intelligence, and business growth — September 24, 2026.
1. Lilly starts a $6.5 billion Houston manufacturing campus
Summary: Eli Lilly broke ground on a 236-acre pharmaceutical manufacturing campus in northeast Houston. The project will produce active pharmaceutical ingredients for its newly approved oral GLP-1 drug and other medicines, while supporting about 4,000 construction jobs and 600 permanent roles.
Why It Matters. The investment turns fast-growing drug demand into a Texas manufacturing and supplier opportunity. Capital alone will not assure output: validated processes, qualified materials, utilities, digital batch records, workforce training, regulatory evidence, and reliable ramp schedules must converge before the plant can generate revenue. Houston also gains a chance to build a durable biomanufacturing cluster rather than a single flagship facility.
Useful Action: Launch a Houston Biomanufacturing Ramp-to-Revenue campaign for contractors and suppliers, using B.O.S.S. to connect specifications, qualification, equipment, workforce, validation, production milestones, and customer demand.
Direct source: Houston Chronicle, September 22, 2026
2. Plan...